Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT00274404
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of infectious mononucleosis with onset no more the 7 days before enrollment; willingness to sign informed consent
* Willingness to provide blood and oral washing samples at regular intervals
* Females must have a negative urine pregnancy test and agree to use effective contraception (barrier or hormonal) for the first 30 days of the study if assigned to valacyclovir
* Corticosteroids are permitted only if prescribed by the subject's primary physisican for treatment of this acute disease
Exclusion Criteria:
* Previous history of mono
* Pregnant or breast feeding
* End-stage renal or liver disease
* Immunosuppressed due to underlying medical disease and/or immunomodulating medications prior to enrollment
* Onset of present illness \>7 days ago
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00274404
Study Brief:
Protocol Section:
NCT00274404